Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders

Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders

US Patent 9669049 · Granted Jun 6, 2017

Estimated economic value: $4,254,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant vectors comprising 2A peptide2022
Recombinant vectors comprising 2A peptide2022
Recombinant vectors comprising 2A peptide2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Formulations of 5-fluorocytosine and uses thereof2021
Formulations of 5-fluorocytosine and uses thereof2021
Retroviral vector with mini-promoter cassette2021
Retroviral vector with mini-promoter cassette2021